A quantitative PCR assay for SV40 neutralization adaptable for high-throughput applications

被引:10
作者
Murata, Haruhiko [1 ]
Teferedegne, Belete [1 ]
Lewis, Andrew M., Jr. [1 ]
Peden, Keith [2 ]
机构
[1] US FDA, Ctr Biol Evaluat & Res, Lab DNA Viruses, Div Viral Prod, Bethesda, MD 20892 USA
[2] US FDA, Ctr Biol Evaluat & Res, Lab Retrovirus Res, Div Viral Prod, Bethesda, MD 20892 USA
关键词
SV40; Polyomavirus; Neutralization; Antibody; Quantitative PCR; SYBR Green; CAPSID PROTEIN; REAL-TIME; BK VIRUS; HEMAGGLUTINATION INHIBITION; PARVOVIRUS B19; HUMAN SERA; POLYOMAVIRUS; IDENTIFICATION; ANTIBODIES; REACTIVITY;
D O I
10.1016/j.jviromet.2009.08.012
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A neutralization assay incorporating a quantitative SYBR Green PCR endpoint has been developed for SV40. The present study demonstrates that crude virus samples can serve as suitable amplification templates for quantitative PCR without the need for nucleic acid extraction. The denaturation temperature of thermocycling appears to be sufficient to release the encapsidated viral genome and allow its availability as a PCR template. Issues arising from inhibitors of PCR present in crude virus samples can be circumvented easily by a 100-fold dilution step. Using a streamlined procedure that eliminates sample nucleic acid extraction (a hitherto rate-limiting step that diminishes throughput substantially), quantitative PCR was applied in order to assess: (1) the replication kinetics of SV40 and (2) the inhibition of SV40 productive infection by neutralizing antibodies. A similar high-throughput approach might be feasible for related polyomaviruses (e.g., BKV and JCV) as well as for other families of viruses. Published by Elsevier B.V.
引用
收藏
页码:236 / 244
页数:9
相关论文
共 34 条
  • [11] NEUTRALIZATION TEST FOR BK VIRUS - PLAQUE REDUCTION DETECTED BY IMMUNOPEROXIDASE STAINING
    FLAEGSTAD, T
    TRAAVIK, T
    CHRISTIE, KE
    JOERGENSEN, J
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1986, 19 (03) : 287 - 296
  • [12] Identification of a novel polyomavirus from patients with acute respiratory tract infections
    Gaynor, Anne M.
    Nissen, Michael D.
    Whiley, David M.
    Mackay, Ian M.
    Lambert, Stephen B.
    Wu, Guang
    Brennan, Daniel C.
    Storch, Gregory A.
    Sloots, Theo P.
    Wang, David
    [J]. PLOS PATHOGENS, 2007, 3 (05) : 595 - 604
  • [13] Hamilton RS, 2000, J CLIN MICROBIOL, V38, P105
  • [14] Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations
    Hirsch, HH
    Brennan, DC
    Drachenberg, CB
    Ginevri, F
    Gordon, J
    Limaye, AP
    Mihatsch, MJ
    Nickeleit, V
    Ramos, E
    Randhawa, P
    Shapiro, R
    Steiger, J
    Suthanthiran, M
    Trofe, J
    [J]. TRANSPLANTATION, 2005, 79 (10) : 1277 - 1286
  • [15] Seroepidemiology of Human Polyomaviruses
    Kean, Jaime M.
    Rao, Suchitra
    Wang, Michael
    Garcea, Robert L.
    [J]. PLOS PATHOGENS, 2009, 5 (03)
  • [16] Relief of amplification inhibition in PCR with bovine serum albumin or T4 gene 32 protein
    Kreader, CA
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1996, 62 (03) : 1102 - 1106
  • [17] Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR
    McNees, AL
    White, ZS
    Zanwar, P
    Vilchez, RA
    Butel, JS
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2005, 34 (01) : 52 - 62
  • [18] Studies of neutralising antibodies to SV40 in human sera
    Minor, P
    Pipkin, P
    Jarzebek, Z
    Knowles, W
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (03) : 490 - 495
  • [19] Identification of a neutralization epitope in the VP1 capsid protein of SV40
    Murata, Haruhiko
    Teferedegne, Belete
    Sheng, Li
    Lewis, Andrew M., Jr.
    Peden, Keith
    [J]. VIROLOGY, 2008, 381 (01) : 116 - 122
  • [20] Identification of a mutation in the SV40 capsid protein VP1 that influences plaque morphology, vacuolization, and receptor usage
    Murata, Haruhiko
    Peden, Keith
    Lewis, Andrew M., Jr.
    [J]. VIROLOGY, 2008, 370 (02) : 343 - 351